<p>TFV-DP levels were measured by LC-MS/MS in increasing numbers of purified blood CD4<sup>+</sup> T cells (A and B) and EM epithelial cells (C) and fibroblasts (D) treated with indicated dose of TFV for 24 hr. Bars represent mean and SEM from triplicate cultures. Values are expressed as fmol per ml in (A) and fmol/million cells in (B, C and D).</p
<p>(<b><u>A</u></b>) Purified CD3<sup>+</sup>CD4<sup>+</sup> T cells were labeled with CFSE and cult...
<p>(<b><u>A</u></b>) Flow cytometry histograms of cultured (d5) CD4<sup>+</sup>CD25<sup>neg</sup> T ...
<p>Blocks of human cervical tissue were infected with C/R or T/F viruses, and cultured <i>ex vivo</i...
<p>TFV-DP levels were measured by LC-MS/MS in purified cultures of EM (n = 4), CX (n = 7) and ECX (n...
<p>TFV-DP levels were measured by LC-MS/MS in purified cultures of epithelial cells (n = 14), fibrob...
<p>TFV-DP levels were measured by LC-MS/MS in purified FRT and blood CD4<sup>+</sup> T cells treated...
<p>TFV-DP levels were measured by LC-MS/MS in polarized cultures of FRT epithelial cells treated wit...
The conflicting results of recent pre-exposure prophylaxis (PrEP) trials utilizing tenofovir (TFV) t...
<p>(A) CD4<sup>+</sup>CD25<sup>hi</sup> percentages within the PBMC population were determined by fl...
<p>Blue, Day 34 (<i>N</i> = 2); red, Day 35 (<i>N</i> = 2); and green, Day 36 (<i>N</i> = 2). The in...
(A) ARV drug and TFV-DP levels in vaginal biopsies collected on Day 7 within 30 min of pod-IVR remov...
<p>Macrophages, DCs were treated with 1mg/ml of TFV for 12, 24 and 48hr and resting and activated CD...
<p>Intracellular TFV-DP and FTC-TP concentrations at 24 h and 3 days in vaginal, rectal, and lymphoi...
(A) ARV drug and TFV-DP levels in vaginal biopsies collected on Day 7 within 30 min of pod-IVR remov...
The conflicting results of recent pre-exposure prophylaxis (PrEP) trials utilizing tenofovir (TFV) t...
<p>(<b><u>A</u></b>) Purified CD3<sup>+</sup>CD4<sup>+</sup> T cells were labeled with CFSE and cult...
<p>(<b><u>A</u></b>) Flow cytometry histograms of cultured (d5) CD4<sup>+</sup>CD25<sup>neg</sup> T ...
<p>Blocks of human cervical tissue were infected with C/R or T/F viruses, and cultured <i>ex vivo</i...
<p>TFV-DP levels were measured by LC-MS/MS in purified cultures of EM (n = 4), CX (n = 7) and ECX (n...
<p>TFV-DP levels were measured by LC-MS/MS in purified cultures of epithelial cells (n = 14), fibrob...
<p>TFV-DP levels were measured by LC-MS/MS in purified FRT and blood CD4<sup>+</sup> T cells treated...
<p>TFV-DP levels were measured by LC-MS/MS in polarized cultures of FRT epithelial cells treated wit...
The conflicting results of recent pre-exposure prophylaxis (PrEP) trials utilizing tenofovir (TFV) t...
<p>(A) CD4<sup>+</sup>CD25<sup>hi</sup> percentages within the PBMC population were determined by fl...
<p>Blue, Day 34 (<i>N</i> = 2); red, Day 35 (<i>N</i> = 2); and green, Day 36 (<i>N</i> = 2). The in...
(A) ARV drug and TFV-DP levels in vaginal biopsies collected on Day 7 within 30 min of pod-IVR remov...
<p>Macrophages, DCs were treated with 1mg/ml of TFV for 12, 24 and 48hr and resting and activated CD...
<p>Intracellular TFV-DP and FTC-TP concentrations at 24 h and 3 days in vaginal, rectal, and lymphoi...
(A) ARV drug and TFV-DP levels in vaginal biopsies collected on Day 7 within 30 min of pod-IVR remov...
The conflicting results of recent pre-exposure prophylaxis (PrEP) trials utilizing tenofovir (TFV) t...
<p>(<b><u>A</u></b>) Purified CD3<sup>+</sup>CD4<sup>+</sup> T cells were labeled with CFSE and cult...
<p>(<b><u>A</u></b>) Flow cytometry histograms of cultured (d5) CD4<sup>+</sup>CD25<sup>neg</sup> T ...
<p>Blocks of human cervical tissue were infected with C/R or T/F viruses, and cultured <i>ex vivo</i...